What a role map is not
A role map is orientation — not a job description, a competency framework, or a statement of what any employer expects of you.
You visit the hospitals and clinics running a trial and check that the trial is being done properly and recorded accurately.
You verify source data against reported data, check consent and investigational product accountability, confirm protocol adherence, and raise findings the site must resolve — across a portfolio of sites you do not manage.
You are the sponsor’s eyes at places it does not control, and the tension in the role is permanent: the sites you assess are also the sites whose cooperation you depend on.
YOUR NEIGHBOURHOOD, IN ONE CONNECTED SYSTEM
Between the sponsor and a portfolio of investigator sites, belonging to neither.
ASSESSMENT · AUTHORITY TO FIND, NOT TO FIX
Working across clients
The eight facets above describe a role inside one organisation. Clinical Research Associate (Monitor) is not in one, so these are the boundaries that replace a reporting line.
WHOSE SYSTEM GOVERNS
The site’s own procedures, read against the protocol and the sponsor’s monitoring plan. Three documents, none of them yours, and reconciling them at each site is the work — a site running trials for several sponsors is following its procedures, not yours.
AUTHORITY
- Findings, with the source evidence behind each
- Where a site process will not survive inspection as it stands
- How the site organises itself or resolves a finding
- Whether a participant continues, which is the investigator’s medical decision
- Whether data is excluded from analysis
BETWEEN ENGAGEMENTS
- Monitoring method and knowing which discrepancies signal a systemic problem
- Familiarity with the protocol and therapeutic area
- One site’s findings, participants or performance, into a conversation at another site
- Any participant-identifying information, anywhere
- Monitoring reports held by the sponsor, and follow-up letters held by the site
- A record of what could not be verified, which matters as much as what could
- Performing site tasks you would later monitor — entering data, or completing records for a site
- Monitoring a site where you previously worked as coordinator on the same study
- Letting the relationship needed for access soften a finding that should be raised
- Data recorded at the site by people who do not report to you
- Database lock and analysis
- The sponsor’s confidence in the data
- Site access and the coordinator’s availability
- Source records existing to be verified against
- A monitoring plan defining what and how much to check
- The sponsor
- Data management and the statisticians downstream
- The verification performed and the findings raised
- Accurate, timely monitoring reports
- How the site runs itself or manages its staff
- Correcting a site’s records — the site corrects its own
- The protocol or the sponsor’s decisions about the study
- The sponsor or CRO study team
- Immediately, for suspected fraud, consent failure or an unreported safety event
- Monitoring visit reports and follow-up letters
- A record of what was verified and what could not be
WHAT THIS ROLE CAN EVIDENCE · 0
No published competency maps to Clinical Research Associate (Monitor) yet. 14 are published across the registry, and this role is not among the ones they name.
Read the standard and its stated coverage →A role map is Locate, moment 2 of 5: what surrounds your work, what you own, and what you escalate. It does not teach the practice or test it. Next is Learn — the Clinical Operations pathway. No scenario exercises this role yet, so Practise comes later for it, then what any of it evidences. Skip any of them — the order does not change.
The regulations and standards this pathway anchors on. SPEQ decodes and cites each one; the authoritative text lives at the official source.
- ICH E6(R3)Good Clinical Practice (GCP)ICH · last revised 2025-01-06
- ICH E8(R1)General Considerations for Clinical StudiesICH · last revised 2021-10-06
- 21 CFR Part 312Investigational New Drug Application (IND)FDA · last revised 2023-01-01
- 21 CFR Part 50Protection of Human Subjects (Informed Consent)FDA · last revised 2024-01-01